| Recent insights into SREBP as a direct mediator of kidney fibrosis via lipid-independent pathways D Dorotea, D Koya, H Ha Frontiers in Pharmacology 11, 510594, 2020 | 67 | 2020 |
| Fyn kinase: A potential therapeutic target in acute kidney injury MJ Uddin, D Dorotea, ES Pak, H Ha Biomolecules & Therapeutics 28 (3), 213, 2020 | 30 | 2020 |
| TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease SM Lee, D Dorotea, I Jung, T Nakabayashi, T Miyata, H Ha Oncotarget 8 (52), 89746, 2017 | 24 | 2017 |
| Orally active, species-independent novel A3 adenosine receptor antagonist protects against kidney injury in db/db mice D Dorotea, A Cho, G Lee, G Kwon, J Lee, PK Sahu, LS Jeong, DR Cha, ... Experimental & Molecular Medicine 50 (4), 1-14, 2018 | 20 | 2018 |
| A pan-NADPH oxidase inhibitor ameliorates kidney injury in type 1 diabetic rats D Dorotea, G Kwon, JH Lee, E Saunders, YS Bae, SH Moon, SJ Lee, ... Pharmacology 102 (3-4), 180-189, 2018 | 18 | 2018 |
| Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stress D Dorotea, S Jiang, ES Pak, JB Son, HG Choi, SM Ahn, H Ha Experimental & Molecular Medicine 54 (8), 1086-1097, 2022 | 16 | 2022 |
| Activation of β2 adrenergic receptor signaling modulates inflammation: a target limiting the progression of kidney diseases D Dorotea, H Ha Archives of Pharmacal Research 44 (1), 49-62, 2021 | 15 | 2021 |
| Impaired Peroxisomal Fitness in Obese Mice, a Vicious Cycle Exacerbating Adipocyte Dysfunction via Oxidative Stress L Piao, D Dorotea, S Jiang, EH Koh, GT Oh, H Ha Antioxidants & Redox Signaling 31 (18), 1339-1351, 2019 | 15 | 2019 |
| Renoprotective potentials of small molecule natural products targeting mitochondrial dysfunction MA Rahman, S Akter, D Dorotea, A Mazumder, MN Uddin, MA Hannan, ... Frontiers in Pharmacology 13, 925993, 2022 | 13 | 2022 |
| Dojuksan ameliorates tubulointerstitial fibrosis through irisin-mediated muscle-kidney crosstalk S Jiang, DS Oh, D Dorotea, E Son, DS Kim, H Ha Phytomedicine 80, 153393, 2021 | 12 | 2021 |
| Peroxisomal Fitness: a potential protective mechanism of Fenofibrate against High Fat Diet-Induced non-alcoholic fatty Liver Disease in mice S Jiang, MJ Uddin, X Yu, L Piao, D Dorotea, GT Oh, H Ha Diabetes & Metabolism Journal 46 (6), 829, 2022 | 9 | 2022 |
| KF-1607, a novel pan src kinase inhibitor, attenuates obstruction-induced tubulointerstitial fibrosis in mice D Dorotea, S Lee, SJ Lee, G Lee, JB Son, HG Choi, SM Ahn, H Ha Biomolecules & Therapeutics 29 (1), 41, 2021 | 9 | 2021 |
| Knockdown of PEX16 induces autophagic degradation of peroxisomes X Wei, Y Maharjan, D Dorotea, RK Dutta, D Kim, H Kim, Y Mu, C Park, ... International Journal of Molecular Sciences 22 (15), 7989, 2021 | 4 | 2021 |
| P0719 SRC kinases aggravate diabetic kidney injury through activation of endoplasmic reticulum stress D Dorotea, H Ha Nephrology Dialysis Transplantation 35 (Supplement_3), gfaa142. P0719, 2020 | 1 | 2020 |
| SRC KINASES AGGRAVATE DIABETIC KIDNEY INJURY THROUGH ACTIVATION OF ENDOPLASMIC RETICULUM STRESS D Dorotea, H Ha NEPHROLOGY DIALYSIS TRANSPLANTATION 35, 1043-1043, 2020 | | 2020 |
| Src kinases inhibition ameliorates diabetic kidney injury in association with decreased endoplasmic reticulum stress D Dorotea International Congress of Diabetes and Metabolism 2018, 192-192, 2018 | | 2018 |
| APX-115, a pan-NADPH oxidase (Nox) inhibitor, attenuates kidney injury in streptozotocin-induced diabetic rats D Dorotea, G Kwon International Congress of Diabetes and Metabolism 2017, 138-138, 2017 | | 2017 |
Junaidi KhotibAirlangga University and Hoshi UniversityVerified email at ff.unair.ac.id
